Patent details

EP2217248 Title: TARGETING MICRORNAS FOR THE TREATMENT OF LIVER CANCER

Basic Information

Publication number:
EP2217248
PCT Application Number:
PCT/US/2008/081645
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP088445960
PCT Publication Number:
WO/2009/058907
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TARGETING MICRORNAS FOR THE TREATMENT OF LIVER CANCER
French Title of Invention:
CIBLAGE DE MICROARN POUR LE TRAITEMENT DU CANCER DU FOIE
German Title of Invention:
TARGETING VON MIKRO-RNAS ZUR BEHANDLUNG VON LEBERKREBS
SPC Number:

Dates

Filing date:
29/10/2008
Grant date:
30/11/2016
EP Publication Date:
30/11/2016
PCT Publication Date:
07/05/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/08/2010
EP B1 Publication Date:
30/11/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/10/2017
Expiration date:
29/10/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/10/2008
 
 

Name:
Regulus Therapeutics Inc.
Address:
10614 Science Center Drive, San Diego, CA 92121, United States (US)

Name:
Rosetta Genomics Ltd.
Address:
10 Plaut Street, 76706 Rehovot, Israel (IL)

Inventor

1

Name:
ESAU Christine
Address:
United States (US)

2

Name:
CHAJUT Ayelet
Address:
Israel (IL)

3

Name:
YERUSHALMI Noga
Address:
Israel (IL)

4

Name:
BENNETT C., Frank
Address:
United States (US)

5

Name:
MARCUSSON Eric, G.
Address:
United States (US)

Priority

Priority Number:
983231 P
Priority Date:
29/10/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/7105;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages